Previous studies indicated that PLK4 was high expressed in several human cancers, including hepatocellular carcinoma, colorectal cancer, gastric cancer, glioblastoma, neuroblastoma, breast cancer, and lung cancer (Zhang et al., 2021), and had a close relationship with the progression of cancers. Here, PLK4 is linked to cancer.